Who Paid My Doc
Kathy Santon
Clinical Nurse Specialist, Psychiatric/Mental Health Avon, IN Clinical Nurse Specialist
NPI 1306897913 CMS profile 10640215
192 N State Road 267, Suite 300, Avon, IN 46123
General payments
$2,325
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Kathy Santon of Avon, IN is reported in the CMS Open Payments database as having received $2,325 across 138 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 76th percentile of Clinical Nurse Specialist, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $210 | 10 | |
| 2022 | General | $385 | 17 | |
| 2021 | General | $1,730 | 111 |
Beside peers
- Kathy Santon
- Clinical Nurse Specialist, Psychiatric/Mental Health median
- Middle half of Clinical Nurse Specialist, Psychiatric/Mental Health
- National median
In program year 2025, general payments to Kathy Santon were reported at $0. Among 300 Clinical Nurse Specialist, Psychiatric/Mental Health profiles paid that year, the median was $245 and the middle half received between $78 and $929.
Show as a table
| Year | Kathy Santon | Clinical Nurse Specialist, Psychiatric/Mental Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $1,730 | $153 | $44–$540 | $132 |
| 2022 | $385 | $207 | $60–$748 | $149 |
| 2023 | $210 | $197 | $55–$898 | $160 |
| 2024 | $0 | $189 | $49–$804 | $164 |
| 2025 | $0 | $245 | $78–$929 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 34 drugsPart D claims
1,070
Drug cost
$85,979
Branded share of claims
26.6%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Rexulti Brexpiprazole | Brand | 16 | $29,321 | |
| Vraylar Cariprazine Hcl | Brand | 16 | $26,623 | |
| Lurasidone Hcl | Generic | 23 | $6,620 | |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | Brand | 66 | $2,404 | |
| Bupropion Xl Bupropion Hcl | Brand | 94 | $2,222 | |
| Aripiprazole | Generic | 30 | $1,887 | |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | Brand | 13 | $1,650 | |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | Brand | 16 | $1,622 | |
| Duloxetine Hcl | Generic | 62 | $1,217 | |
| Gabapentin | Generic | 57 | $1,015 |
The 10 drugs with the highest cost, of 34 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,644 Part D prescribers listed as Certified Clinical Nurse Specialist; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 4 billing codesPaid by Medicare
$10,840
Medicare patients
43
Services billed
221
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Depression | 75% | |
| High blood pressure | 74% | |
| Arthritis | 58% | |
| Diabetes | 33% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
138 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Nurse Specialist, Psychiatric/Mental Health in Indiana
Gerald Lewis
Clinical Nurse Specialist, Psychiatric/Mental Health · Merrillville, IN
Sharon Clevenger
Clinical Nurse Specialist, Psychiatric/Mental Health · Fort Wayne, IN
Sandra Sperling
Clinical Nurse Specialist, Psychiatric/Mental Health · Merrillville, IN
Ursula McCormick
Clinical Nurse Specialist, Psychiatric/Mental Health · Bloomington, IN
Alicia Elliott
Clinical Nurse Specialist, Psychiatric/Mental Health · Fort Wayne, IN
Amy Scheeringa
Clinical Nurse Specialist, Psychiatric/Mental Health · Auburn, IN
Related records
Clinical Nurse Specialist, Psychiatric/Mental Health in Indiana
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Nurse Specialist, Psychiatric/Mental Health
Everyone recorded under this specialty, nationwide.
Doctors in Indiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.